comparemela.com

Latest Breaking News On - Novu aesthetics - Page 1 : comparemela.com

Axington facing risk of being delisted

This comes after the company notified the Singapore Exchange Securities Trading (SGX-ST) on April 1 of its cash company status according to Catalist listing rules, given that it does not currently have any “revenue-generating business”, according to an exchange filing on Tuesday. SINGAPORE: Catalist-listed Axington, linked to the scandal-hit Loh cousins, is now a cash company and faces the risk of delisting if it does not acquire a new business within a year. This comes after the company notified the Singapore Exchange Securities Trading (SGX-ST) on April 1 of its cash company status according to Catalist listing rules, given that it does not currently have any “revenue-generating business”, according to an exchange filing on Tuesday.

Evening Update: Today s headlines from The Straits Times on March 9

The Straits Times Good evening! Catch up on some of the main headlines on Tuesday, March 9. PublishedMar 9, 2021, 6:39 pm SGT https://str.sg/Jjpy They can read the article in full after signing up for a free account. Share link: Or share via: Sign up or log in to read this article in full Sign up All done! This article is now fully available for you Read now Get unlimited access to all stories at $0.99/month for the first 3 months. Get unlimited access to all stories at $0.99/month for the first 3 months. including the ST News Tablet worth $398. Let s go! Spin the wheel for ST Read and Win now.

Patients unable to book treatments at Novu Aesthetics clinics; 35 complaints filed

SINGAPORE - A lack of funds at Novu Aesthetics, a chain of clinics run under a subsidiary of the troubled Novena Global Healthcare (NGH) co-founded by Singaporean cousins Nelson and Terence Loh, has led to doctors being taken off the roster, some staff left unpaid, and patients unable to book treatments. Two of its six clinics, at Raffles City and Northpoint mall, have also permanently shuttered, The Straits Times has confirmed. Please subscribe or log in to continue reading the full article. Get unlimited access to all stories at $0.99/month Latest headlines and exclusive stories In-depth analyses and award-winning multimedia content

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.